Inventor · disambiguated record
Seiji Nukui
Also filed as: NUKUI SEIJI
23 granted patents·3 pending applications·257 citations·filing 2000–2025
96Inventor score
Top patents by PatentIndex Score
26 records- 0193US8877761B2N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitorsLI HUI·Filed 2012·Granted Nov 4, 2014·19 cites·17 claims
- 0291US7842713B2Fused phenyl amido heterocyclic compoundsPFIZER·Filed 2007·Granted Nov 30, 2010·13 cites·15 claims
- 0390US9518060B2Substituted pyrrolo[3,4-c]pyrazoles as PKC kinase inhibitorsPFIZER·Filed 2014·Granted Dec 13, 2016·11 cites·10 claims
- 0490US8183255B2N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitorsLI HUI·Filed 2008·Granted May 22, 2012·12 cites·20 claims
- 0590US7479564B2Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agentsRAQUALIA PHARMA INC·Filed 2006·Granted Jan 20, 2009·21 cites·13 claims
- 0690US6979690B2Oxo or oxy-pyridine compounds as 5-HT4 receptor modulatorsPFIZER·Filed 2003·Granted Dec 27, 2005·46 cites·11 claims
- 0788US10167253B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2016·Granted Jan 1, 2019·6 cites·16 claims
- 0888US6710054B2Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agentsPFIZER·Filed 2001·Granted Mar 23, 2004·35 cites·16 claims
- 0986US11384051B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2018·Granted Jul 12, 2022·2 cites·14 claims
- 1084US10316045B2Substituted pyrrolo[3,4-c]pyrazoles as pkc kinase inhibitorsPFIZER·Filed 2016·Granted Jun 11, 2019·3 cites·16 claims
- 1183US7238714B2Aryl or heteroaryl amide compoundsPFIZER JAPAN INC·Filed 2004·Granted Jul 3, 2007·30 cites·27 claims
- 1283US7141580B2Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agentsPFIZER·Filed 2004·Granted Nov 28, 2006·19 cites·12 claims
- 1381US8114871B23-amido-pyrrolo[3,4-C]pyrazole-5(1H,4H,6H) carbaldehyde derivativesBOTROUS IRINY·Filed 2008·Granted Feb 14, 2012·6 cites·14 claims
- 1480US11220518B2Substituted n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as protein kinase C inhibitorsPFIZER·Filed 2019·Granted Jan 11, 2022·1 cites·5 claims
- 1579US12319643B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2022·Granted Jun 3, 2025·0 cites·12 claims
- 1679US11780853B2Substituted N-pyrimidin-4-yl-3-aminopyrrolo[3,4-C]pyrazoles as protein kinase C inhibitorsPFIZER·Filed 2021·Granted Oct 10, 2023·0 cites·15 claims
- 1779US6686373B2Pyrazoloquinolinone derivatives as protein kinase C inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Feb 3, 2004·14 cites·29 claims
- 1878US8999981B23-amido-pyrrolo[3,4-C]pyrazole-5(1H, 4H,6H) carbaldehyde derivativesBOTROUS IRINY·Filed 2012·Granted Apr 7, 2015·5 cites·12 claims
- 1977US2025250226A1Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2025·Application pending·0 cites
- 2075US8119624B2Fused phenyl amido heterocyclic compoundsBAI HAO·Filed 2010·Granted Feb 21, 2012·4 cites·7 claims
- 2169US6444677B25-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonistsPFIZER·Filed 2000·Granted Sep 3, 2002·6 cites·9 claims
- 2268US7001917B2Pyrazole compounds as anti-inflammatory and analgesic agentsWARNER LAMBERT CO·Filed 2003·Granted Feb 21, 2006·4 cites·13 claims
- 2350US2024270809A1Oral glp receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2449US2010256357A1Heterocycles useful as inhibitors of carbonic anhydraseAGOURON PHARMA·Filed 2007·Application pending·0 cites
- 2544US9078926B2Polymer conjugates with a linkerNITTO DENKO CORP·Filed 2013·Granted Jul 14, 2015·0 cites·19 claims
- 2641US6734306B2N-benzenesulfonyl L-proline compounds as bradykinin antagonistsPFIZER·Filed 2001·Granted May 11, 2004·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Seiji Nukui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →